Yifan Pharmaceutical Co., Ltd. (002019.SZ)
CNY 11.38
(0.53%)
CNY 11.38
(0.53%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 928.6 Million CNY | 11.75% |
| 2022 | 830.97 Million CNY | 25.17% |
| 2021 | 663.87 Million CNY | 13.71% |
| 2020 | 583.85 Million CNY | -2.4% |
| 2019 | 598.18 Million CNY | 25.19% |
| 2018 | 477.83 Million CNY | 21.83% |
| 2017 | 392.2 Million CNY | 4.17% |
| 2016 | 376.49 Million CNY | 2.17% |
| 2015 | 368.48 Million CNY | 30.1% |
| 2014 | 283.22 Million CNY | 91.83% |
| 2013 | 147.64 Million CNY | -4.03% |
| 2012 | 153.84 Million CNY | -11.28% |
| 2011 | 173.41 Million CNY | 41.97% |
| 2010 | 122.14 Million CNY | 37.41% |
| 2009 | 88.88 Million CNY | -22.76% |
| 2008 | 115.08 Million CNY | 44.8% |
| 2007 | 79.48 Million CNY | 73.2% |
| 2006 | 45.88 Million CNY | -21.46% |
| 2005 | 58.42 Million CNY | 64.0% |
| 2004 | 35.62 Million CNY | 69.88% |
| 2003 | 20.97 Million CNY | 10.49% |
| 2002 | 18.98 Million CNY | 60.45% |
| 2001 | 11.82 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.07 Billion CNY | 9.43% |
| 2024 Q1 | 985.94 Million CNY | 6.17% |
| 2024 Q3 | 1.06 Billion CNY | -1.34% |
| 2023 FY | 928.6 Million CNY | 11.75% |
| 2023 Q2 | 979.71 Million CNY | 4.81% |
| 2023 Q3 | 985.04 Million CNY | 0.54% |
| 2023 Q4 | 928.6 Million CNY | -5.73% |
| 2023 Q1 | 934.75 Million CNY | 12.49% |
| 2022 Q1 | 712.05 Million CNY | 7.26% |
| 2022 Q3 | 838.72 Million CNY | 5.69% |
| 2022 FY | 830.97 Million CNY | 25.17% |
| 2022 Q2 | 793.61 Million CNY | 11.45% |
| 2022 Q4 | 830.97 Million CNY | -0.93% |
| 2021 Q1 | 604.88 Million CNY | 3.6% |
| 2021 Q4 | 663.87 Million CNY | 1.76% |
| 2021 FY | 663.87 Million CNY | 13.71% |
| 2021 Q2 | 632.06 Million CNY | 4.49% |
| 2021 Q3 | 652.38 Million CNY | 3.22% |
| 2020 Q3 | 575.72 Million CNY | -8.28% |
| 2020 Q1 | 592.96 Million CNY | -0.87% |
| 2020 FY | 583.85 Million CNY | -2.4% |
| 2020 Q2 | 627.66 Million CNY | 5.85% |
| 2020 Q4 | 583.85 Million CNY | 1.41% |
| 2019 Q4 | 598.18 Million CNY | -1.67% |
| 2019 Q3 | 608.35 Million CNY | 8.8% |
| 2019 FY | 598.18 Million CNY | 25.19% |
| 2019 Q1 | 511.72 Million CNY | 7.09% |
| 2019 Q2 | 559.13 Million CNY | 9.26% |
| 2018 Q4 | 477.83 Million CNY | 17.91% |
| 2018 Q1 | 389.89 Million CNY | -0.59% |
| 2018 FY | 477.83 Million CNY | 21.83% |
| 2018 Q2 | 375.58 Million CNY | -3.67% |
| 2018 Q3 | 405.24 Million CNY | 7.9% |
| 2017 FY | 392.2 Million CNY | 4.17% |
| 2017 Q3 | 383.92 Million CNY | 6.23% |
| 2017 Q2 | 361.41 Million CNY | 2.44% |
| 2017 Q1 | 352.8 Million CNY | -6.29% |
| 2017 Q4 | 392.2 Million CNY | 2.16% |
| 2016 FY | 376.49 Million CNY | 2.17% |
| 2016 Q1 | 371.81 Million CNY | 0.9% |
| 2016 Q2 | 373.13 Million CNY | 0.36% |
| 2016 Q4 | 376.49 Million CNY | -5.61% |
| 2016 Q3 | 398.85 Million CNY | 6.89% |
| 2015 Q4 | 368.48 Million CNY | 8.95% |
| 2015 Q3 | 338.21 Million CNY | 17.71% |
| 2015 Q2 | 287.32 Million CNY | 0.37% |
| 2015 Q1 | 286.25 Million CNY | 1.07% |
| 2015 FY | 368.48 Million CNY | 30.1% |
| 2014 Q4 | 283.22 Million CNY | 5.8% |
| 2014 Q3 | 267.69 Million CNY | 47.79% |
| 2014 Q1 | 165.59 Million CNY | 12.16% |
| 2014 Q2 | 181.13 Million CNY | 9.38% |
| 2014 FY | 283.22 Million CNY | 91.83% |
| 2013 FY | 147.64 Million CNY | -4.03% |
| 2013 Q4 | 147.64 Million CNY | -6.25% |
| 2013 Q3 | 157.48 Million CNY | 4.48% |
| 2013 Q2 | 150.73 Million CNY | 6.74% |
| 2013 Q1 | 141.21 Million CNY | -8.21% |
| 2012 FY | 153.84 Million CNY | -11.28% |
| 2012 Q2 | 190.62 Million CNY | -6.85% |
| 2012 Q4 | 153.84 Million CNY | -2.44% |
| 2012 Q3 | 157.68 Million CNY | -17.28% |
| 2012 Q1 | 204.64 Million CNY | 18.01% |
| 2011 Q2 | 150.7 Million CNY | 12.72% |
| 2011 Q4 | 173.41 Million CNY | 11.48% |
| 2011 Q3 | 155.55 Million CNY | 3.22% |
| 2011 Q1 | 133.69 Million CNY | 9.46% |
| 2011 FY | 173.41 Million CNY | 41.97% |
| 2010 Q2 | 142.06 Million CNY | 40.36% |
| 2010 Q4 | 122.14 Million CNY | 5.66% |
| 2010 Q3 | 115.59 Million CNY | -18.63% |
| 2010 FY | 122.14 Million CNY | 37.41% |
| 2010 Q1 | 101.21 Million CNY | 13.87% |
| 2009 Q1 | 84.83 Million CNY | -26.28% |
| 2009 Q4 | 88.88 Million CNY | -10.76% |
| 2009 FY | 88.88 Million CNY | -22.76% |
| 2009 Q2 | 86.55 Million CNY | 2.02% |
| 2009 Q3 | 99.6 Million CNY | 15.08% |
| 2008 FY | 115.08 Million CNY | 44.8% |
| 2008 Q3 | 102.53 Million CNY | 2.11% |
| 2008 Q2 | 100.41 Million CNY | 5.17% |
| 2008 Q1 | 95.48 Million CNY | 20.14% |
| 2008 Q4 | 115.08 Million CNY | 12.24% |
| 2007 Q2 | 56.2 Million CNY | 44.01% |
| 2007 Q1 | 39.02 Million CNY | -14.95% |
| 2007 Q3 | 57.07 Million CNY | 1.54% |
| 2007 Q4 | 79.48 Million CNY | 39.27% |
| 2007 FY | 79.48 Million CNY | 73.2% |
| 2006 Q1 | 47.3 Million CNY | -19.03% |
| 2006 Q3 | 33.01 Million CNY | -12.08% |
| 2006 FY | 45.88 Million CNY | -21.46% |
| 2006 Q4 | 45.88 Million CNY | 38.98% |
| 2006 Q2 | 37.55 Million CNY | -20.61% |
| 2005 FY | 58.42 Million CNY | 64.0% |
| 2005 Q1 | 42.93 Million CNY | 20.51% |
| 2005 Q2 | 42.11 Million CNY | -1.9% |
| 2005 Q3 | 33.67 Million CNY | -20.05% |
| 2005 Q4 | 58.42 Million CNY | 73.51% |
| 2004 FY | 35.62 Million CNY | 69.88% |
| 2004 Q3 | 40.05 Million CNY | 9.18% |
| 2004 Q2 | 36.68 Million CNY | 0.0% |
| 2004 Q4 | 35.62 Million CNY | -11.06% |
| 2003 FY | 20.97 Million CNY | 10.49% |
| 2003 Q4 | 20.97 Million CNY | 0.0% |
| 2002 FY | 18.98 Million CNY | 60.45% |
| 2001 FY | 11.82 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 3.57 Billion CNY | 73.994% |
| Zhejiang Zhenyuan Share Co., Ltd. | 679.41 Million CNY | -36.677% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 64.57 Million CNY | -1337.97% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 298.99 Million CNY | -210.581% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 84.6 Million CNY | -997.643% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 3.83 Billion CNY | 75.816% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 170.99 Million CNY | -443.055% |
| Boai NKY Medical Holdings Ltd. | 309.8 Million CNY | -199.742% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 59.03 Million CNY | -1472.91% |